PERKINELMER, INC.
$NYSE:PKI
55 watching
PERKINELMER, INC.
$NYSE:PKI
55 watching

Could PerkinElmer Be The Next Danaher?

Can a restructuring lead to outperformance?

PerkinElmer, Inc. (PKI) is an American Medical Devices company focused on life sciences and diagnostics. Over the last ten years, the company outperformed the S&P 500 by a wide margin but did not manage to beat the...

more

PerkinElmer: Reiterate Buy, Next Price Objective $155/Share

Investment Summary

From the Portfolio Manager's desk

Following its latest set of numbers, I've sized up our position and reiterated our buy call on PerkinElmer, Inc. (PKI) shares. Here, we run through the synopsis backing the call. Our first price...

more

PerkinElmer's EONIS SCID-SMA assay kit gets FDA approval for use in newborns

Trending News

PerkinElmer, Inc. is a global leader in life sciences. They supply instruments, software, services, and consumables for applications across the research, drug discovery, and clinical diagnostics markets. PerkinElmer's EONIS SCID-SMA assay kit has been granted approval by the US FDA...

more

PerkinElmer receives FDA approval for EONIS assay for spinal muscular atrophy in newborns

  • The US FDA has granted approval to PerkinElmer's (NYSE:PKI) EONIS SCID-SMA assay kit for in vitro diagnostic (IVD) use for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.
  • The...

more

PerkinElmer, Inc. (PKI) Q3 2022 Earnings Call Transcript

PerkinElmer, Inc. (PKI)

Q3 2022 Earnings Conference Call

November 8, 2022 8:00 AM ET

Company Participants

Steve Willoughby - Senior Vice President, Investor Relations

Prahlad Singh - President and Chief Executive Officer

Max...

more

PerkinElmer, Inc. 2022 Q3 - Results - Earnings Call Presentation

The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2022 Q3 earnings call.

...

- SA Transcripts

https://seekingalpha.com/article/4554684-perkinelmer-inc-2022-q3-results-...

$NYSE:PKI

136.92 -0.3%
USD, PERKINELMER, INC.
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See more
Trending Topics
$NASDAQ:META
1577 Discussions
$NASDAQ:MSFT
1038 Discussions
#Metaverse
42 Discussions

All statements, views or opinions expressed here are the personal views of our users. They do not represent nor should they be construed as representing our statements, views or opinions. For the avoidance of doubt, any such statements, views or opinions are not and shall not be construed as financial advice.

Make Smart Investment Choices